SCHEMBL5134813

SCHEMBL5134813

C[Si](C)(CCNC(=O)CCS)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.42
HDAC4 P56524 3/20 0.42
HDAC1 Q13547 3/20 0.42
HDAC7 Q8WUI4 3/20 0.42
HDAC2 Q92769 3/20 0.42
HDAC10 Q969S8 3/20 0.42
HDAC11 Q96DB2 3/20 0.42
HDAC8 Q9BY41 3/20 0.42
HDAC6 Q9UBN7 3/20 0.42
HDAC9 Q9UKV0 3/20 0.42
HDAC5 Q9UQL6 3/20 0.42
MAPT P10636 1/20 0.42
CYP3A4 P08684 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SREBF2 Q12772 1/20 0.39
EPHX2 P34913 1/20 0.37
PTAFR P25105 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5139867 0.84 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5097544 0.76 HPGD (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5090684 0.76 ALDH1A1 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4393503 0.75 POLB (0.37) HDAC1MAPTCYP3A4CYP1A2ALDH1A1
SCHEMBL4393512 0.75 POLB (0.37) HDAC1MAPTCYP3A4CYP1A2ALDH1A1
SCHEMBL2009313 0.71 CHRNA7 (0.46) CYP3A4CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL15592301 0.67 SREBF2 (0.60) CYP3A4CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL16610103 0.66 CYP3A4 (0.61) HDAC2HDAC8HDAC6MAPTCYP3A4
SCHEMBL4397742 0.66 POLB (0.38) MAPTALDH1A1CA1CA2CA9
SCHEMBL4397733 0.66 POLB (0.38) MAPTALDH1A1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968609-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND Pharmaceuticals, Inc. (US) 2008-09-17 EP disclosed
WO-2007073560-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND PHARMACEUTICALS, INC. (US) 2007-06-28 WO disclosed